Health
AstraZeneca-Ionis Trial Failure in Heart Disease Drug
AstraZeneca and Ionis faced a setback with their heart disease drug trial, marking a significant development in the competitive pharmaceutical market.
Coverage timeline — 1 article
STAT News
AstraZeneca and Ionis reported a notable trial failure Thursday in a heart disease that's become an increasingly competitive market for drugmakers.
2026-07-09 09:13 UTC